Medicilon participated in the annual meeting of the American Chinese Biomedical Technology Association on Christmas Eve

The 27th Annual Chinese Biopharmaceutical Association (CBA) Meeting will be held on December 17, 2022, at the Marriott Washingtonian Center in Maryland!

This year, Medicilon went to the site and set up a booth to participate in the exhibition. The theme of this conference is "Empowering Healthcare with Cutting-Edge Biopharma Technologies and Leading Global Partnerships,"

The content of the meeting covers the frontier results of basic research. It includes the latest progress in the research and development of drugs such as small molecules, immune checkpoint inhibitors, CMC, siRNA, ADC, and precision medicine. There are in-depth discussions on government approval and regulatory policies and more analysis and outlook on the challenges and opportunities faced by biotechnology investment. During the meeting, the Medicilon team promoted our comprehensive services, such as drug discovery and antibody discovery, through exchanges with the participants and demonstrated our professional capabilities in innovative drug research and development services.